Wu YINGMING

Person

  • Shanghai, CN

Patents Grantslast 30 patents

  • Information Patent Grant

    Compounds as MYT1 inhibitors

    • Patent number 12,122,774
    • Issue date Oct 22, 2024
    • WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
    • Yuli Xie
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    COMPOUNDS USED AS SRC INHIBITORS

    • Publication number 20250042904
    • Publication date Feb 6, 2025
    • WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
    • Yuli XIE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AS MYT1 INHIBITORS

    • Publication number 20240287067
    • Publication date Aug 29, 2024
    • WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
    • Yuli XIE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    FUSED RING COMPOUND AS WEE-1 INHIBITOR

    • Publication number 20240182447
    • Publication date Jun 6, 2024
    • WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
    • Yuli XIE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PYRIMIDINE COMPOUND AS WEE-1 INHIBITOR

    • Publication number 20240158369
    • Publication date May 16, 2024
    • WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
    • Yuli XIE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NEW PYRAZINE COMPOUND

    • Publication number 20230167099
    • Publication date Jun 1, 2023
    • WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
    • Yuli XIE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS

    • Publication number 20220289732
    • Publication date Sep 15, 2022
    • Novartis AG
    • Lichao FANG
    • C07 - ORGANIC CHEMISTRY